時価総額 変化する 日付
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 209.65B 14.21B 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Cytokinetics USD 9.6B 1.95B 2026-08
Enanta Pharmaceuticals USD 122M 98M 2024-12
Gilead Sciences USD 168.68B 11.82B 2026-08
Incyte USD 26.84B 4.19B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Karyopharm Therapeutics USD 221M 95M 2026-08
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 153.17B 14.73B 2026-08
Roche Holding CHF 270B 3.66B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
TG Therapeutics USD 7.63B 778M 2026-08
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08
Xencor USD 1.21B 19M 2026-08